OC
MDXH icon

Oppenheimer & Co’s MDxHealth MDXH Stock Holding History

Oppenheimer & Co’s Portfolio MDXH Stock Details MDXH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-20,000
Closed -$44.2K – 1706
2025
Q2 		$44.2K Hold
20,000
– – ﹤0.01% 1586
2025
Q1 		$28.4K Hold
20,000
– – ﹤0.01% 1552
2024
Q4 		$47.4K Buy
20,000
+10,000
+100% +$20.4K ﹤0.01% 1529
2024
Q3 		$20.8K Buy
+10,000
New +$27.2K ﹤0.01% 1495

Other funds holding MDXH

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
SM
Samjo Management New York $231M AUM 13.04% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
FL
FreeGulliver LLC New Orleans, Louisiana $237M AUM 21.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return

Oppenheimer & Co's MDXH Position: Q3 2025 in Review

Oppenheimer & Co sold out of MDxHealth (MDXH) in Q3 2025, closing a stake of 20,000 shares — an estimated $44.2K sold.

Oppenheimer & Co first reported a position in MDXH in Q3 2024 and held it in 4 quarters. The position peaked at $47.4K in Q4 2024. 42 funds tracked by Wall St. Rank hold MDXH as of Q3 2025.

  • Oppenheimer & Co reported no remaining MDxHealth position as of Q3 2025 after selling out during the quarter.
  • Oppenheimer & Co sold 20,000 MDxHealth shares in Q3 2025, an estimated $44.2K.
  • Oppenheimer & Co first reported a position in MDxHealth in Q3 2024 and held it in 4 quarters.
  • Oppenheimer & Co's MDxHealth position peaked at $47.4K in Q4 2024.
  • 42 funds tracked by Wall St. Rank held MDxHealth as of Q3 2025.

Based on Oppenheimer & Co's 13F filing for Q3 2025, filed 6 Nov 2025.